A UN-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck’s COVID-19 pill to...
A trial of Pfizer Inc’s experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89 percent the chances of...
Merck & Co Inc said on Wednesday the U.S. government has agreed to pay about US$1.2 billion for 1.7 million courses of its experimental COVID-19 treatment,...